18805 COX AVENUE SUITE 250, SARATOGA, CA
CapsoVision Enters $100 Million Controlled Equity Offering Agreement
Reports Second Quarter 2026 Financial Results
Material disclosure
Shareholder votes
Reports First Quarter 2026 Financial Results
Material Contracts, Financial Results, Unregistered Sales of Equity Securities, Reg. FD, Other Events
CapsoVision Enters $4.1 Million Development Agreement with Canon Inc.
Announces 510(k) Submission for the Addition of AI-Assisted Reading Module in CapsoCam Plus®
Q2
Q1
FY 2025
Q3
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(3)
S-1
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Free Writing Prospectus
Amended Form D Notice of Exempt Offering of Securities